Skip to main content
PROTIA INC. logo

PROTIA INC. — Investor Relations & Filings

Ticker · 303360 ISIN · KR7303360002 KO Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2023-04-17 Report Publication Anno…
Country KR South Korea
Listing KO 303360

About PROTIA INC.

https://www.protia.co.kr/en/main

PROTIA INC. is an in-vitro diagnostics (IVD) company that develops, manufactures, and sells a wide range of diagnostic kits and instruments. The company is particularly known for its flagship product, PROTIA Allergy-Q, a multiplex allergy diagnostic kit for the quantitative determination of allergen-specific IgE. Its portfolio also includes point-of-care testing (POCT) solutions like the ImmuneCheck IgG kit, diagnostic tests for infectious and autoimmune diseases, cancer, and antibiotic susceptibility, as well as the ANITIA line for companion animal allergy testing. In addition to its product offerings, PROTIA provides comprehensive protein analysis services, including LC-MS/MS and characterization analysis, aiming to contribute to early disease prediction and diagnosis through innovative technology.

Recent filings

Filing Released Lang Actions
[기재정정]기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a regulatory filing (specifically a 'Correction Report' or 'Amendment') regarding the scheduling of an Investor Relations (IR) event. It details the change in date for an upcoming corporate presentation. Since it is an announcement regarding the scheduling and logistics of an IR event rather than the presentation materials themselves, and it is a formal regulatory filing, it falls under the RNS category as a general regulatory announcement.
2023-04-17 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal notice announcing the scheduling of an Investor Relations (IR) presentation/briefing. It provides details such as the date, time, location (online), target audience, and purpose (listing on the KOSDAQ market). Since this is an announcement of an upcoming event rather than the presentation materials themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a standard corporate disclosure regarding investor relations activities.
2023-04-10 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) from ProteomeTech regarding a decision for a paid-in capital increase (유상증자결정). It details the number of new shares, issuance price, purpose of funds, and subscription procedures for an IPO/public offering. This is a formal regulatory filing announcing a capital change and share issuance, which falls under the 'Share Issue/Capital Change' category.
2023-04-04 Korean
증권신고서(지분증권) (2023.04)
Share Issue/Capital Change Classification · 1% confidence The document is a '증권신고서' (Securities Registration Statement) filed by ProteomeTech Inc. with the Financial Services Commission (FSC) in South Korea. It details the company's intent to offer shares, provides comprehensive risk factors, financial projections, and business descriptions for the purpose of a public offering and KOSDAQ listing. This document is a formal regulatory filing required for capital raising and does not fit into the 'Report Publication Announcement' (RPA) category because it is the primary regulatory document itself, not an announcement of one. It is best classified as a Regulatory Filing (RNS) as it is a formal submission to a financial regulator.
2023-04-04 Korean
기타주요경영사항(자율공시)(코스닥시장 상장예비심사 승인)
Regulatory Filings Classification · 1% confidence The document is a regulatory announcement from ProteomeTech regarding the approval of its preliminary review for KOSDAQ market listing. It is a short, formal disclosure of a specific corporate event (listing progress) rather than a full financial report or a report publication announcement. As it pertains to general regulatory disclosure of a material corporate event, it falls under the RNS (Regulatory Filings) category.
2023-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and details the outcomes of the meeting held on 2023-03-28, including the approval of financial statements, election of directors, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2023-03-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.